HCA Healthcare, Inc. (HCA)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
HCA Healthcare, Inc. (HCA) trades at $410.50 with AI Score 86/100 (Grade A+). HCA Healthcare, Inc. is a leading provider of healthcare services in the United States, operating a vast network of hospitals and outpatient facilities. Market cap: $91.07B, Sector: Healthcare.
Price live · AI analysis from May 10, 2026HCA stock analysis for 2026: Analysts have set a consensus price target of $537.13 for HCA Healthcare, Inc., suggesting 30.8% upside from the current price of $410.50. The AI MoonshotScore is 86/100, indicating a strong bullish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.
HCA: 5/7 perspectives are bullish. Dominant signal: Ray Dalio bullish.
How is this calculated? →HCA Healthcare, Inc. (HCA) Healthcare & Pipeline Overview
HCA Healthcare, Inc. stands as a premier healthcare services provider in the U.S., operating a comprehensive network of hospitals and outpatient facilities, delivering a wide array of medical and surgical services while maintaining a focus on quality patient care and operational excellence.
What Is the Investment Thesis for HCA?
HCA Healthcare, Inc. presents a compelling investment thesis driven by its robust market position and operational efficiency. With a market capitalization of $91.07B and a P/E ratio of 12.9, HCA demonstrates strong profitability, evidenced by a profit margin of 8.9% and a gross margin of 34.9%. The company is well-positioned to benefit from the ongoing expansion of healthcare services, particularly as the demand for outpatient care continues to rise. HCA's strategic focus on operational excellence, combined with its extensive network of facilities, allows it to capture market share in an increasingly competitive landscape. Additionally, the company's dividend yield of 0.68% provides a steady income stream for investors. However, potential risks, including regulatory changes and market competition, must be monitored closely as they could impact future growth.
Based on FMP financials and quantitative analysis
HCA Key Highlights
- Market capitalization of $91.07B indicates strong market presence in the healthcare sector.
- P/E ratio of 12.9 reflects a competitive valuation relative to peers.
- Profit margin of 8.9% demonstrates effective cost management and operational efficiency.
- Gross margin of 34.9% exceeds industry averages, indicating strong profitability.
- Dividend yield of 0.68% provides a steady return to shareholders.
Who Are HCA's Competitors?
HCA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| PFE Pfizer Inc. | $24.32 | +1.84% | $138.61B | 64 |
| BMY Bristol-Myers Squibb Company | $58.13 | +2.99% | $118.71B | 88 |
| SNY Sanofi | $43.16 | +3.68% | $103.77B | 58 |
| VRTX Vertex Pharmaceuticals Incorporated | $528.04 | +6.03% | $134.02B | 99 |
| CVS CVS Health Corporation | $104.72 | -0.09% | $133.62B | 74 |
| HWAIF Healwell AI Inc. | $0.55 | +5.07% | $166.74M | 65 |
| SLHGP Skylight Health Group Inc. | $12.00 | -5.88% | 61 | |
| TOI The Oncology Institute, Inc. | $5.28 | -4.17% | $527.91M | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are HCA's Key Strengths?
- Large scale of operations with 182 hospitals and numerous outpatient facilities.
- Strong financial performance with consistent revenue growth.
- Diverse service offerings catering to a wide range of patient needs.
- Established reputation for quality care and patient satisfaction.
What Are HCA's Weaknesses?
- High operational costs associated with running extensive healthcare facilities.
- Regulatory challenges in the healthcare industry may impact operations.
- Dependence on government reimbursement programs for a significant portion of revenue.
- Potential vulnerabilities to economic downturns affecting patient volumes.
What Could Drive HCA Stock Higher?
- Expansion of outpatient services to meet rising patient demand.
- Strategic acquisitions to enhance geographic reach and service offerings.
- Investment in technology to improve operational efficiency and patient care.
- Initiatives to expand mental health services in response to societal needs.
What Are the Key Risks for HCA?
- Insider selling — insiders were net sellers of roughly $23.2M recently.
- Regulatory changes impacting reimbursement rates and operational practices.
- Competition from other healthcare providers and emerging startups.
- Economic fluctuations affecting patient volumes and insurance coverage.
- Rising costs of healthcare delivery impacting profit margins.
What Are the Growth Opportunities for HCA?
- Expansion of Outpatient Services: HCA is poised to capitalize on the growing trend towards outpatient care, which is projected to reach a market size of $100 billion by 2025. By enhancing its outpatient facilities and services, HCA can attract more patients seeking convenient, cost-effective care options.
- Technological Advancements in Healthcare: The integration of advanced technologies in healthcare delivery is expected to drive significant growth. HCA's investment in telehealth services and electronic health records positions the company to improve patient outcomes and operational efficiency, tapping into a market projected to grow at a CAGR of 15% through 2026.
- Strategic Acquisitions: HCA has a history of strategic acquisitions that enhance its service offerings and geographic reach. With a focus on acquiring complementary healthcare facilities, HCA can expand its footprint in underserved markets, potentially increasing its patient base and revenue streams.
- Aging Population: The increasing number of elderly individuals in the U.S. is expected to drive demand for healthcare services. HCA's comprehensive service offerings, particularly in geriatric care, position it to meet this rising demand, contributing to sustained revenue growth over the next decade.
- Mental Health Services Expansion: HCA's operation of psychiatric hospitals allows it to address the growing need for mental health services, which is projected to grow to a $240 billion market by 2030. By enhancing its mental health programs, HCA can capture a larger share of this expanding market.
What Opportunities Does HCA Have?
- Growing demand for outpatient services driven by patient preferences.
- Expansion into new geographic markets to capture additional patient demographics.
- Increased focus on mental health services to meet rising societal needs.
- Partnerships with technology firms to enhance telehealth offerings.
What Threats Does HCA Face?
- Intense competition from other healthcare providers and emerging startups.
- Regulatory changes that may affect reimbursement rates and operational practices.
- Economic fluctuations impacting patient volumes and insurance coverage.
- Rising costs of healthcare delivery and potential margin pressures.
What Are HCA's Competitive Advantages?
- Extensive network of hospitals and outpatient facilities enhances accessibility.
- Strong brand recognition and reputation for quality care in the healthcare sector.
- Diverse service offerings reduce dependency on any single revenue stream.
- Operational efficiencies gained from scale provide a competitive advantage.
- Commitment to innovation and technology adoption improves patient care.
What Does HCA Do?
HCA Healthcare, Inc., founded in 1968, is a prominent health care services company headquartered in Nashville, Tennessee. Originally known as HCA Holdings, Inc., the company has evolved significantly over the decades, expanding its operations to become one of the largest healthcare providers in the United States. HCA operates a diverse range of healthcare facilities, including general and acute care hospitals, outpatient surgery centers, and urgent care facilities, among others. As of December 31, 2021, HCA managed 182 hospitals, comprising 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals across 20 states and England. The company also boasts a robust network of outpatient healthcare facilities, including 125 freestanding surgery centers and 21 freestanding endoscopy centers. HCA's extensive service offerings encompass inpatient care, intensive care, cardiac care, diagnostic and emergency services, as well as outpatient services like laboratory, radiology, and physical therapy. HCA's commitment to providing high-quality healthcare is evident in its operational strategies and the therapeutic programs offered in its psychiatric hospitals, which cater to various demographics. With a workforce of approximately 320,000 employees, HCA is dedicated to advancing healthcare delivery and improving patient outcomes through its comprehensive and innovative services.
What Products and Services Does HCA Offer?
- Operate general and acute care hospitals providing comprehensive medical services.
- Offer outpatient services including surgery, laboratory, and rehabilitation.
- Manage freestanding ambulatory surgery and emergency care centers.
- Provide psychiatric care and substance abuse treatment programs.
- Deliver diagnostic imaging and therapy services through specialized centers.
- Engage in community health initiatives to improve overall public health.
How Does HCA Make Money?
- Generate revenue through patient services in hospitals and outpatient facilities.
- Offer specialized medical services that cater to diverse patient needs.
- Leverage economies of scale across a large network of healthcare facilities.
- Implement cost management strategies to enhance profitability.
- Engage in partnerships and collaborations to expand service offerings.
What Industry Does HCA Operate In?
The healthcare industry, particularly the medical care facilities sector, is experiencing significant growth driven by an aging population and increasing demand for healthcare services. The market is projected to expand as technological advancements and shifts towards outpatient care reshape service delivery. HCA Healthcare, Inc. is strategically positioned within this landscape, leveraging its extensive network of hospitals and outpatient facilities to meet the evolving needs of patients. The competitive landscape includes major players like Pfizer Inc. (PFE), Bristol-Myers Squibb Company (BMY), Sanofi (SNY), Vertex Pharmaceuticals Incorporated (VRTX), and CVS Health Corporation (CVS), all vying for market share in a rapidly changing environment.
Who Are HCA's Key Customers?
- Patients seeking inpatient and outpatient medical care.
- Insurance companies providing coverage for healthcare services.
- Government programs such as Medicare and Medicaid.
- Employers offering health benefits to employees.
- Community organizations and health agencies collaborating on public health initiatives.
Company Profile
HCA Healthcare, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Nashville, US. The company is led by CEO Samuel N. Hazen. HCA has traded publicly since 2011.
How HCA Healthcare, Inc. Is Valued
HCA Healthcare, Inc. carries a market capitalization of $91.07B, placing it in the large-cap category. Relative to its peer group, HCA's quantitative score of 86/100 is roughly in line with the peer average of 77/100.
P/E 12.9Key Financial Metrics
Return on assets is 11.1%, showing how much profit it generates from its asset base. HCA trades at a trailing price-to-earnings ratio of 12.95, below the Healthcare sector average of ~23x. Its free cash flow yield is 9.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.83 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 7.7%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 7/9Financial Health
HCA Healthcare, Inc.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 2.54 places it in the grey zone, a middle ground that warrants monitoring.
FY2026 estForward Outlook
Wall Street analysts project HCA Healthcare, Inc. revenue of about $78.53B for fiscal 2026, with EPS near $30.23. The estimate reflects 18 contributing analysts.
Net buyingInsider Activity
Over the past six months, HCA Healthcare, Inc. insiders filed 30 SEC Form 4 transactions — 12 sales and 18 purchases. On net that is roughly 66K shares acquired (about $23.2M) — insiders putting money in tends to read as conviction.
HCA Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- HCA's insider activity suggests confidence, with recent buying possibly signaling undervaluation.
- Community sentiment leans bullish, fueled by positive perceptions of HCA's stability in the healthcare sector.
- Market perception views HCA as a defensive play, attractive during economic uncertainty. Think healthcare demand is relatively constant.
- Bullish voices highlight HCA's strong market position and ability to navigate regulatory changes.
Bear Case
- Recent insider selling may indicate concerns about future performance or market conditions.
- Bearish community members express concerns about rising costs and potential margin compression.
- Market perception acknowledges regulatory risks and potential impacts on HCA's profitability.
- Bearish voices point to increasing competition and potential challenges in maintaining market share.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
From the Earnings Call
“We estimate the adjusted EBITDA impact from the exchanges to be approximately $150 million in the first quarter of 2026 versus the prior year quarter.”
— Mike Marks, CFO
“Given our experience to date, we still believe our full year range of $600 million to $900 million expected impact on adjusted EBITDA is appropriate.”
— Mike Marks, CFO
HCA Q1 FY2026 earnings call transcript · 2026-04-24
HCA Latest News
-
Can Encompass Health's Expansion Strategy Drive Its Next Growth Phase?
Yahoo! Finance: HCA News · Jun 29, 2026
-
HCA Healthcare Announces New Research Published In NEJM Highlighting Results From Gene-Editing Therapy Being Investigated In Children With Severe Sickle Cell Disease And Transfusion-Dependent Beta Thalassemia
benzinga · Jun 29, 2026
-
HCA Healthcare Announces New England Journal of Medicine Study Highlighting Advances in CRISPR-based Therapy for Children
businesswire.com · Jun 29, 2026
-
TD Cowen Cuts PT on HCA Healthcare (HCA) But Remains Bullish
Yahoo! Finance: HCA News · Jun 28, 2026
HCA Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for HCA.
Price Targets
Consensus target: $537.13
HCA MoonshotScore
What does this score mean?
The MoonshotScore rates HCA's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
Can Encompass Health's Expansion Strategy Drive Its Next Growth Phase?
HCA Healthcare Announces New Research Published In NEJM Highlighting Results From Gene-Editing Therapy Being Investigated In Children With Severe Sickle Cell Disease And Transfusion-Dependent Beta Thalassemia
HCA Healthcare Announces New England Journal of Medicine Study Highlighting Advances in CRISPR-based Therapy for Children
TD Cowen Cuts PT on HCA Healthcare (HCA) But Remains Bullish
Leadership: Samuel N. Hazen
CEO
Samuel N. Hazen has been with HCA Healthcare for over 30 years, holding various leadership roles that have shaped the company's strategic direction. He holds a Bachelor of Science in Business Administration from the University of Florida and has extensive experience in healthcare management and operations.
Track Record: Under Hazen's leadership, HCA has achieved significant operational efficiencies and expanded its service offerings, enhancing patient care and satisfaction. He has been instrumental in driving HCA's growth strategy, including strategic acquisitions and technological advancements.
Common Questions About HCA (Healthcare)
What does HCA Healthcare, Inc. do?
HCA Healthcare, Inc. operates a comprehensive network of hospitals and outpatient facilities across the United States. The company provides a wide range of healthcare services, including inpatient and outpatient care, surgical services, psychiatric treatment, and rehabilitation. With a focus on quality patient care, HCA is dedicated to improving health outcomes through its extensive service offerings.
What do analysts say about HCA stock?
Analysts generally view HCA Healthcare, Inc. positively, citing its strong market position and financial performance. Key valuation metrics indicate a P/E ratio of 12.9, which is competitive within the industry. Analysts highlight the company's growth potential driven by increasing demand for healthcare services and operational efficiencies, while also noting the need to monitor regulatory risks.
What are the main risks for HCA?
HCA Healthcare, Inc. faces several risks that could impact its business operations and financial performance. Regulatory changes in the healthcare industry may affect reimbursement rates, while competition from other healthcare providers could pressure market share. Additionally, economic fluctuations may influence patient volumes and insurance coverage, posing challenges to revenue stability.
What are the key factors to evaluate for HCA?
HCA Healthcare, Inc. (HCA) holds an AI score of 86/100 (high). P/E: 12.9x vs the S&P 500's ~20-25x. Analysts target $537.13 (+31%). Not financial advice.
How frequently does HCA data refresh on this page?
HCA prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven HCA's recent stock price performance?
HCA Healthcare, Inc. (HCA) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Large scale of operations with 182 hospitals and numerous outpatient facilities. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider HCA overvalued or undervalued right now?
HCA Healthcare, Inc. (HCA) trades at 12.9x earnings. Analysts target $537.13 (+31%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying HCA?
Before investing in HCA Healthcare, Inc. (HCA), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- All information is based on the latest available data and may be subject to change.